The present study aimed to elucidate the mechanism underlying the suppression of oxidative stress in gliomas by propofol and to investigate whether propofol affects DMT1 expression by modifying CPARs and consequently influences the tumor redox status. This evidence concerns the gene SLC11A2 and glioma.